This research service outlines the technologies on influenza therapeutics.

Table Of Contents

Influenza Therapeutics--Developments and Trends (Technical Insights)
Table of Contents

1 | EXECUTIVE SUMMARY

Industry Overview and Key Research Highlights
1. Industry Overview
2. Key Research Highlights

Scope and Methodology
1. Scope
2. Methodology

2 | GLOBAL RandD NETWORK ANALYSIS

Value Chain Analysis
1. Existing RandD Networks
2. Stakeholders RandD Focus

Environmental Assessment
1. Key Technology Drivers
2. Key Technology Challenges
3. Analysis of the Business Environment--Porter's Analysis
4. Analysis of the Internal Environment--SWOT Analysis

3 | STRATEGIC MANAGEMENT OF RandD

Industry Trends and Requirements
1. Current Industry and Research Trends
2. Technical Resource Competency
3. RandD Intensity
4. Availability of Funding and Future Milestones

RandD Management Strategy
1. Technology Strategy
2. RandD Strategy

New Product Development and Commercialization Strategy
1. Innovation Strategy
2. Intellectual Property (IP) Protection Strategy
3. Conclusion

4 | PATENTS AND KEY CONTACTS

Patents
1. Issued Patents across Industry and Academia
2. Applied Patents across Industries and Academia

Key Participants
1. Participants across Industry
2. Participants across Academia

5 | DECISION SUPPORT DATABASE

DSD Tables
1. Incidence of Haemophilus Influenzae--USA (2004 to 2014)
2. Government Investment in Biotech RandD (Million USD)--World (2004 to 2014)
3. Pharma RandD Expenditure (Million USD)--World (2004 to 2014)
4. Pharmaceutical Market (Billion USD)--World (2004 to 2014)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Renal Cell Carcinoma: KOL Insight

Renal Cell Carcinoma: KOL Insight

  • $ 6 695
  • Industry report
  • February 2015
  • by Firstword Pharma

Will new checkpoint inhibitors revive immunotherapy in RCC? Renal Cell Carcinoma: KOL Insight offers opinions of 12 leading US and European KOLs that present business-critical insights for branded pharma ...

Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets

Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets

  • $ 6 650
  • Industry report
  • March 2015
  • by BCC Research

REPORT HIGHLIGHTS The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound ...

Nonalcoholic Steatohepatitis: KOL Insight

Nonalcoholic Steatohepatitis: KOL Insight

  • $ 6 495
  • Industry report
  • March 2015
  • by Firstword Pharma

Why This Report is Essential Expect a revolution in the treatment of nonalcoholic steatohepatitis (NASH) as a number of new therapies compete to become the first approved treatment for a disease that ...


Download Unlimited Documents from Trusted Public Sources

Therapy Industry in the US - Forecast

  • May 2015
    177 pages
  • Hospital  

  • United States  

View report >

Global Oncology Markets

  • May 2015
    51 pages
  • Cancer Therapy  

    Healthcare  

    Oncology  

  • United States  

    World  

View report >

Chemotherapy Market in the US

  • April 2015
    2 pages
  • Chemotherapy  

    Oncology  

    Cancer Therapy  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.